Skip to Content

Listeria Outbreak Spurs Recall of Queso Fresco Cheeses

MONDAY, Feb. 22, 2021 -- All Queso Fresco cheeses made by El Abuelito Cheese Inc. have been recalled after being linked to a Listeria outbreak in four states, the U.S. Food and Drug Administration said.

There have been seven illnesses so far reported, with four in Maryland, one in Connecticut, one in New York, and one in Virginia. All seven patients were hospitalized.

The recall covers all Queso Fresco products -- including El Abuelito, Rio Grande, and Rio Lindo brand queso frescos -- that have "sell by" dates through 03/28/21 and were distributed in Connecticut, Maryland, North Carolina, New Jersey, New York, Pennsylvania, and Virginia. A full list of the recalled products can be found here.

Consumers, restaurants, and retailers should not eat, sell, or serve the recalled products, the FDA said. Consumers should be especially vigilant about cleaning and sanitizing any surfaces and containers that may have come in contact with the recalled cheeses, the agency advised. Listeria can survive in refrigerated temperatures and easily spreads to other foods and surfaces.

More Information

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Many Older Adults Keep and Use Leftover Antibiotics

FRIDAY, Feb. 26, 2021 -- A sizable minority of older adults have used antibiotics for a nonintended purpose, according to research published online Feb. 5 in Infection Control...

CDC Expands Alert About Listeria Outbreak Linked to Cheese

THURSDAY, Feb. 25, 2021 -- Consumers and businesses should not eat, sell, or serve any cheese sold under the brand name El Abuelito, the U.S. Centers for Disease Control and...

CDC Investigating Listeria Outbreak in Four States

FRIDAY, Feb. 12, 2021 -- Seven people in four states have been hospitalized in a Listeria outbreak linked to potentially contaminated cheese, U.S. health officials said...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.